Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1316Triple Negative Breast Neoplasms 233Ovarian Neoplasms 115Carcinoma, Non-Small-Cell Lung 89Colorectal Neoplasms 86Neoplasm Metastasis 83Prostatic Neoplasms 79Neoplasms 76Lung Neoplasms 70Melanoma 57Pancreatic Neoplasms 54Endometrial Neoplasms 54Stomach Neoplasms 49Uterine Cervical Neoplasms 44Carcinoma, Intraductal, Noninfiltrating 41Squamous Cell Carcinoma of Head and Neck 38Colonic Neoplasms 37Head and Neck Neoplasms 33Carcinoma, Renal Cell 33Esophageal Neoplasms 27Breast Carcinoma In Situ 27Small Cell Lung Carcinoma 25Sarcoma 25Brain Neoplasms 25Urinary Bladder Neoplasms 22Anatomic Stage I Breast Cancer AJCC v8 22Carcinoma, Transitional Cell 20Advanced Breast Cancer 18Liver Neoplasms 17Gastrointestinal Neoplasms 17

Interventions

trastuzumab biosimilar HLX02 1exemestane 1X-Rays 1Trastuzumab 1Taxes 1TVB-2640 1Specimen Handling 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Magnetic Resonance Spectroscopy 1Letrozole 1Fulvestrant 1Disulfides 1CT-P6 1Biopsy 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Breast Carcinoma × Breast × 90 days × Clear all
NCT03179904 2026-05-05

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

Mayo Clinic

Phase 2 Active not recruiting
17 enrolled 10 charts
Breast

Advanced Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡